Company / Total Assets
GeneDx Holdings Corp. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$523.7M
FY2025
5-year range
$418.8M / $554.1M
FY2021-FY2025
Trend
+24.9%
vs FY2024
Sector context
#142 of 166
Health Care
What the data says
GeneDx Holdings Corp.'s total assets of $524M is lower than 86% of companies in the Health Care sector (FY2025). Improved from $419M to $524M over the past 2 years.
Based on SEC 10-K filings.
$524M in FY2025 with a 5-year CAGR of +15.8%.
Improved from $419M to $524M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 166This company $523.7M Sector average $14.9B
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2025, total assets increased 24.9% year-over-year.
- Ranks #142 out of 166 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $523.7M | +24.9% |
| FY2024 | $419.4M | +0.1% |
| FY2023 | $418.8M | -14.7% |
| FY2022 | $490.9M | -11.4% |
| FY2021 | $554.1M | +120.2% |
| FY2020 | $251.6M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026